Among them, there were 7 mutation sites of importance for HT-related genes [CTLA4 (1 site), BACH2 (3 sites), and RNASET2 (3 sites)] where at least two patients with thyroid cancer experienced mutations. Here, CTLA4 is linked to thyroid gland carcinoma.